These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 729766)

  • 1. [1 model for the prognosis of anticonvulsive and antiparkinson agents].
    Ianishevs'ka NO; Piniazhko RM
    Farm Zh; 1978; (6):68-72. PubMed ID: 729766
    [No Abstract]   [Full Text] [Related]  

  • 2. [Correction of a prognostic model].
    Zahorovs'ka LT; Ianishevs'kyĭ AT
    Farm Zh; 1979; (4):60-4. PubMed ID: 477946
    [No Abstract]   [Full Text] [Related]  

  • 3. [Age profile of patients treated with psychopharmaceuticals].
    Kameníková L; Stika L; Plechatová H
    Cesk Farm; 1978 Jun; 27(4):182-7. PubMed ID: 699072
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effectiveness of the use of new types of antiparkinson agents].
    Federmann J; Honzáková L; Roth B; Stika L
    Cesk Zdrav; 1981 Jun; 29(6):229-41. PubMed ID: 7261170
    [No Abstract]   [Full Text] [Related]  

  • 5. Polypharmacy in the treatment of schizophrenic patients in three University Centers in the Federation of Bosnia and Herzegovina (F/BH).
    Loga-Zec S; Loga S
    Psychiatr Danub; 2011 Mar; 23(1):60-3. PubMed ID: 21448098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of anticholinergic antiparkinson agents against adverse drug reactions in a psychiatric department. A quality assurance project].
    Mikkelsen VR
    Ugeskr Laeger; 1998 Jul; 160(29):4323-5. PubMed ID: 9679438
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antiparkinsonian drug consumption in a University Hospital Center 1981-1990].
    Lapeyre-Mestre M; Chave B; Rascol O; Senard JM; Lafont J; Montastruc JL
    Therapie; 1992; 47(5):444-5. PubMed ID: 1299997
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in psychotropic drugs in the Japanese pharmaceutical industry.
    Nakamura K
    Rev Pure Appl Pharmacol Sci; 1980; 1(4):357-80. PubMed ID: 6116263
    [No Abstract]   [Full Text] [Related]  

  • 9. [Problems of neurological drug therapy in pregnancy].
    Piccione E; Ticconi C; Cennamo M
    Clin Ter; 1989 Apr; 129(2):139-44. PubMed ID: 2526000
    [No Abstract]   [Full Text] [Related]  

  • 10. Utilization of antiparkinsonian drugs in Sweden, 1974-1987.
    Hartvig P; Gudjónsson O; Aquilonius SM
    Adv Neurol; 1990; 53():387-9. PubMed ID: 2239479
    [No Abstract]   [Full Text] [Related]  

  • 11. [Epidemiological assessment of levodopa consumption].
    de Pedro-Cuesta J; Cuadrado JI
    Rev Neurol; 2000 Dec 1-15; 31(11):1028-30. PubMed ID: 11190867
    [No Abstract]   [Full Text] [Related]  

  • 12. [Creutzfeldt-Jakob disease].
    Tanii H; Takeda M
    Ryoikibetsu Shokogun Shirizu; 2003; (40):319-23. PubMed ID: 14626130
    [No Abstract]   [Full Text] [Related]  

  • 13. Auditing antiparkinsonism drugs: guidelines for appropriate medication use.
    Marttila JK; Green BA
    Contemp Pharm Pract; 1979; 2(1):11-4. PubMed ID: 10241632
    [No Abstract]   [Full Text] [Related]  

  • 14. Acanthocytosis and spinocerebellar degeneration: a new association?
    Tsai CH; Chen RS; Chang HC; Lu CS; Liao KK
    Mov Disord; 1997 May; 12(3):456-9. PubMed ID: 9159749
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic effectiveness of drugs as determined by DESI reports. II.
    Calesnick B
    Semin Drug Treat; 1973; 3(3):315-9. PubMed ID: 4130521
    [No Abstract]   [Full Text] [Related]  

  • 16. The response of "de novo" Parkinson's disease patients to bromocriptine in a "low and slow" regimen is predictive for prognosis.
    Sampaio C; Coelho T; Castro-Caldas A; Bastos-Lima A; Levy A
    J Neural Transm Suppl; 1995; 45():197-202. PubMed ID: 8748626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How best to address these common movement disorders.
    Yaman A; Akdeniz M; Yaman H
    J Fam Pract; 2011 Dec; 60(12):721-5. PubMed ID: 22163354
    [No Abstract]   [Full Text] [Related]  

  • 18. A survey of psychotropic medication in mental retardation facilities.
    Tu JB
    J Clin Psychiatry; 1979 Mar; 40(3):125-8. PubMed ID: 33967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug interactions of central nervous system active drugs. 3: Drug interactions of anticonvulsants and antiparkinson agents].
    Estler CJ
    Fortschr Med; 1984 Feb; 102(6):129-32. PubMed ID: 6706270
    [No Abstract]   [Full Text] [Related]  

  • 20. Nationwide use of medicines for Alzheimer's disease by community-dwelling persons in Finland.
    Alander J; Lönnroos E; Hartikainen S; Klaukka T
    J Am Geriatr Soc; 2006 Mar; 54(3):557-8. PubMed ID: 16551340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.